These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 29691127)

  • 1. Digenic Heterozigosity in SCN5A and CACNA1C Explains the Variable Expressivity of the Long QT Phenotype in a Spanish Family.
    Nieto-Marín P; Jiménez-Jáimez J; Tinaquero D; Alfayate S; Utrilla RG; Rodríguez Vázquez Del Rey MDM; Perin F; Sarquella-Brugada G; Monserrat L; Brugada J; Tercedor L; Tamargo J; Delpón E; Caballero R
    Rev Esp Cardiol (Engl Ed); 2019 Apr; 72(4):324-332. PubMed ID: 29691127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complex Brugada syndrome inheritance in a family harbouring compound SCN5A and CACNA1C mutations.
    Béziau DM; Barc J; O'Hara T; Le Gloan L; Amarouch MY; Solnon A; Pavin D; Lecointe S; Bouillet P; Gourraud JB; Guicheney P; Denjoy I; Redon R; Mabo P; le Marec H; Loussouarn G; Kyndt F; Schott JJ; Probst V; Baró I
    Basic Res Cardiol; 2014; 109(6):446. PubMed ID: 25341504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional characterization of a novel SCN5A variant associated with long QT syndrome and sudden cardiac death.
    Neubauer J; Wang Z; Rougier JS; Abriel H; Rieubland C; Bartholdi D; Haas C; Medeiros-Domingo A
    Int J Legal Med; 2019 Nov; 133(6):1733-1742. PubMed ID: 31455979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the CACNA1C-R518C Missense Mutation in the Pathobiology of Long-QT Syndrome Using Human Induced Pluripotent Stem Cell Cardiomyocytes Shows Action Potential Prolongation and L-Type Calcium Channel Perturbation.
    Estes SI; Ye D; Zhou W; Dotzler SM; Tester DJ; Bos JM; Kim CSJ; Ackerman MJ
    Circ Genom Precis Med; 2019 Aug; 12(8):e002534. PubMed ID: 31430211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired chromaffin cell excitability and exocytosis in autistic Timothy syndrome TS2-neo mouse rescued by L-type calcium channel blockers.
    Calorio C; Gavello D; Guarina L; Salio C; Sassoè-Pognetto M; Riganti C; Bianchi FT; Hofer NT; Tuluc P; Obermair GJ; Defilippi P; Balzac F; Turco E; Bett GC; Rasmusson RL; Carbone E
    J Physiol; 2019 Mar; 597(6):1705-1733. PubMed ID: 30629744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and Functional Characterization of a Novel CACNA1C-Mediated Cardiac Disorder Characterized by Prolonged QT Intervals With Hypertrophic Cardiomyopathy, Congenital Heart Defects, and Sudden Cardiac Death.
    Boczek NJ; Ye D; Jin F; Tester DJ; Huseby A; Bos JM; Johnson AJ; Kanter R; Ackerman MJ
    Circ Arrhythm Electrophysiol; 2015 Oct; 8(5):1122-32. PubMed ID: 26253506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel long QT syndrome-associated missense mutation, L762F, in CACNA1C-encoded L-type calcium channel imparts a slower inactivation tau and increased sustained and window current.
    Landstrom AP; Boczek NJ; Ye D; Miyake CY; De la Uz CM; Allen HD; Ackerman MJ; Kim JJ
    Int J Cardiol; 2016 Oct; 220():290-8. PubMed ID: 27390944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further Insights in the Most Common SCN5A Mutation Causing Overlapping Phenotype of Long QT Syndrome, Brugada Syndrome, and Conduction Defect.
    Veltmann C; Barajas-Martinez H; Wolpert C; Borggrefe M; Schimpf R; Pfeiffer R; Cáceres G; Burashnikov E; Antzelevitch C; Hu D
    J Am Heart Assoc; 2016 Jul; 5(7):. PubMed ID: 27381756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gain-of-function mutation in SCN5A causes ventricular arrhythmias and early onset atrial fibrillation.
    Lieve KV; Verkerk AO; Podliesna S; van der Werf C; Tanck MW; Hofman N; van Bergen PF; Beekman L; Bezzina CR; Wilde AAM; Lodder EM
    Int J Cardiol; 2017 Jun; 236():187-193. PubMed ID: 28262340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human iPS cell model of type 3 long QT syndrome recapitulates drug-based phenotype correction.
    Malan D; Zhang M; Stallmeyer B; Müller J; Fleischmann BK; Schulze-Bahr E; Sasse P; Greber B
    Basic Res Cardiol; 2016 Mar; 111(2):14. PubMed ID: 26803770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A distinct molecular mechanism by which phenytoin rescues a novel long QT 3 variant.
    Gando I; Campana C; Tan RB; Cecchin F; Sobie EA; Coetzee WA
    J Mol Cell Cardiol; 2020 Jul; 144():1-11. PubMed ID: 32339567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Digenic inheritance novel mutations in SCN5a and SNTA1 increase late I(Na) contributing to LQT syndrome.
    Hu RM; Tan BH; Orland KM; Valdivia CR; Peterson A; Pu J; Makielski JC
    Am J Physiol Heart Circ Physiol; 2013 Apr; 304(7):H994-H1001. PubMed ID: 23376825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variable Penetrance and Expressivity of a Rare Pore Loss-of-Function Mutation (p.L889V) of Nav1.5 Channels in Three Spanish Families.
    Gallego-Delgado M; Cámara-Checa A; Rubio-Alarcón M; Heredero-Jung D; de la Fuente-Blanco L; Rapún J; Plata-Izquierdo B; Pérez-Martín S; Cebrián J; Moreno de Redrojo L; García-Berrocal B; Delpón E; Sánchez PL; Villacorta E; Caballero R
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel mutation in SCN5A, delQKP 1507-1509, causing long QT syndrome: role of Q1507 residue in sodium channel inactivation.
    Keller DI; Acharfi S; Delacrétaz E; Benammar N; Rotter M; Pfammatter JP; Fressart V; Guicheney P; Chahine M
    J Mol Cell Cardiol; 2003 Dec; 35(12):1513-21. PubMed ID: 14654377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gain-of-function mutations in the calcium channel CACNA1C (Cav1.2) cause non-syndromic long-QT but not Timothy syndrome.
    Wemhöner K; Friedrich C; Stallmeyer B; Coffey AJ; Grace A; Zumhagen S; Seebohm G; Ortiz-Bonnin B; Rinné S; Sachse FB; Schulze-Bahr E; Decher N
    J Mol Cell Cardiol; 2015 Mar; 80():186-95. PubMed ID: 25633834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The molecular genetics of the long QT syndrome: genes causing fainting and sudden death.
    Vincent GM
    Annu Rev Med; 1998; 49():263-74. PubMed ID: 9509262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long QT syndrome type 8: novel CACNA1C mutations causing QT prolongation and variant phenotypes.
    Fukuyama M; Wang Q; Kato K; Ohno S; Ding WG; Toyoda F; Itoh H; Kimura H; Makiyama T; Ito M; Matsuura H; Horie M
    Europace; 2014 Dec; 16(12):1828-37. PubMed ID: 24728418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac sodium channel mutation associated with epinephrine-induced QT prolongation and sinus node dysfunction.
    Chen J; Makiyama T; Wuriyanghai Y; Ohno S; Sasaki K; Hayano M; Harita T; Nishiuchi S; Yuta Yamamoto ; Ueyama T; Shimizu A; Horie M; Kimura T
    Heart Rhythm; 2016 Jan; 13(1):289-98. PubMed ID: 26282245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A sodium channel pore mutation causing Brugada syndrome.
    Pfahnl AE; Viswanathan PC; Weiss R; Shang LL; Sanyal S; Shusterman V; Kornblit C; London B; Dudley SC
    Heart Rhythm; 2007 Jan; 4(1):46-53. PubMed ID: 17198989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient-independent human induced pluripotent stem cell model: A new tool for rapid determination of genetic variant pathogenicity in long QT syndrome.
    Chavali NV; Kryshtal DO; Parikh SS; Wang L; Glazer AM; Blackwell DJ; Kroncke BM; Shoemaker MB; Knollmann BC
    Heart Rhythm; 2019 Nov; 16(11):1686-1695. PubMed ID: 31004778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.